Recurrence and Complications Following Uncomplicated Diverticulitis

AUGUST 06, 2013
Michele Reed, PharmD, RPh
A recent prospective study assessed the risk of a recurrent attack following the first episode of uncomplicated diverticulitis.3 Investigators enrolled patients (n = 280) admitted between January 2007 and December 2011 with a first episode of uncomplicated sigmoid diverticulitis confirmed on computed tomography. Follow-up was conducted after the first episode was successfully managed. Investigators utilized Cox proportional hazards regression to model the impact of various parameters on eventual recurrences and complications.

Results demonstrated that 16.4% of patients experienced a second episode of diverticulitis during the 24-month follow-up. Six patients (2.1%) subsequently developed complicated diverticulitis, and 4 patients (1.4%) underwent emergency surgery for peritonitis.

A multivariable analysis demonstrated that a raised serum level of C-reactive protein (over 240 mg/L) during the first attack was associated with early recurrence (hazard ratio 1.75; 95% CI, 1.04-2.94; P = .035). The authors concluded that there were few recurrences and little need for emergency surgery associated with uncomplicated diverticulitis.


Dr. Reed is a freelance writer in Fairless Hills, Pennsylvania.

References
  1. Marcus CL, Moore RH, Rosen CL, et al. A randomized trial of adenotonsillectomy for childhood sleep apnea. N Engl J Med. 2013;368(25):2366-2376.
  2. Leuppi JD, Schuetz P, Bingisser R, et al. Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial. JAMA. 2013;309(21):2223-2231.
  3. Buchs NC, Konrad-Mugnier B, Jannot AS, et al. Assessment of recurrence and complications following uncomplicated diverticulitis. Br J Surg. 2013;100(7):976-979.
 


SHARE THIS SHARE THIS
0

Become A RESPIMAT T.O.P. Performer 

Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc.

Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today?


Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.